The Food and Drug Administration in 2021 granted approval to a controversial treatment for Alzheimer's disease, but a congressional investigation has called into question whether the agency followed proper procedure in granting its seal of approval.
https://americasvoice.news/justthenews/fda-approval-alzheimers-drug-rife-irregularities-probe-concludes/